Bora Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	8,431	5,077	5,829	3,053	3,281	910.75
Short-Term Investments	39.8	38.37	67.86	342.63	247.62	-
Trading Asset Securities	19.02	20.28	20.28	-	-	-
Cash & Short-Term Investments	8,490	5,136	5,917	3,396	3,529	910.75
Cash Growth	94.46%	-13.21%	74.25%	-3.77%	287.48%	35.94%
Accounts Receivable	10,124	9,260	10,482	4,028	6,120	824.77
Other Receivables	411.04	344.91	766.08	82.61	286.38	33.23
Receivables	10,535	9,604	11,248	4,111	6,407	858.01
Inventory	4,184	3,410	5,502	2,157	1,991	928.64
Prepaid Expenses	796.5	675.46	591	801.43	242.47	63.07
Other Current Assets	390.12	511.69	118.63	138.63	71.58	31.87
Total Current Assets	24,396	19,338	23,377	10,604	12,241	2,792
Property, Plant & Equipment	11,617	11,183	12,510	7,494	7,300	4,067
Long-Term Investments	5,586	5,929	236.33	21.26	62.03	-
Goodwill	-	2,664	3,618	3,010	983.59	-
Other Intangible Assets	8,438	3,580	3,920	2,665	1,164	171.05
Long-Term Deferred Tax Assets	1,102	1,170	1,190	1,045	829.64	243.78
Other Long-Term Assets	938.54	849.81	657.62	294.85	181.01	98.65
Total Assets	52,077	44,714	45,510	25,134	22,761	7,372
Accounts Payable	974.65	925.1	792.34	380.45	454.74	235.81
Accrued Expenses	123.52	130.72	252.47	30.86	29.33	321.24
Short-Term Debt	5,328	3,950	2,598	767.51	2,161	645.48
Current Portion of Long-Term Debt	-	1,691	1,189	630.5	725.63	222.09
Current Portion of Leases	135.8	80.62	116.6	106.04	75.31	17.54
Current Income Taxes Payable	342.35	321.05	484.33	987.43	238.65	50.58
Current Unearned Revenue	315.27	262.52	245.6	224.6	85.69	20.47
Other Current Liabilities	11,598	5,960	8,130	5,102	6,725	327.91
Total Current Liabilities	18,817	13,321	13,808	8,229	10,496	1,841
Long-Term Debt	13,314	11,796	14,324	2,724	4,037	1,028
Long-Term Leases	752.38	708.9	745.96	763.33	596.88	305.97
Long-Term Unearned Revenue	20.28	88.87	-	-	4.18	-
Pension & Post-Retirement Benefits	91.44	99.39	129.04	115.36	136.41	136.28
Long-Term Deferred Tax Liabilities	1,044	988.55	1,256	783.9	742.85	609.77
Other Long-Term Liabilities	501.45	239.08	323.59	753.09	1,608	298.57
Total Liabilities	34,542	27,242	30,586	13,368	17,621	4,220
Common Stock	1,277	1,274	1,031	1,014	753.82	684.12
Additional Paid-In Capital	6,445	6,056	4,408	3,318	1,236	1,026
Retained Earnings	7,652	8,346	7,020	4,729	2,549	1,466
Treasury Stock	-166.91	-134.29	-43.18	-50.97	-53.09	-
Comprehensive Income & Other	-83.49	-159.75	362.83	74.66	42.2	-23.26
Total Common Equity	15,125	15,381	12,779	9,085	4,528	3,153
Minority Interest	2,411	2,091	2,144	2,681	612.13	-
Shareholders' Equity	17,535	17,472	14,923	11,766	5,140	3,153
Total Liabilities & Equity	52,077	44,714	45,510	25,134	22,761	7,372
Total Debt	19,531	18,227	18,973	4,991	7,596	2,219
Net Cash (Debt)	-11,041	-13,091	-13,056	-1,595	-4,067	-1,308
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-58.34	-69.41	-92.49	-12.84	-34.34	-11.20
Filing Date Shares Outstanding	127.47	126.99	123.39	121.33	117.01	117.32
Total Common Shares Outstanding	127.47	126.99	123.39	121.33	117.01	117.32
Working Capital	5,578	6,017	9,569	2,375	1,745	951.22
Book Value Per Share	118.66	121.12	103.57	74.88	38.70	26.87
Tangible Book Value	6,687	9,137	5,241	3,410	2,381	2,981
Tangible Book Value Per Share	52.46	71.95	42.47	28.10	20.35	25.41
Land	-	3,758	3,824	3,424	3,397	1,984
Buildings	-	7,289	7,963	1,945	1,905	1,393
Machinery	-	3,870	6,113	2,814	2,390	859.79
Construction In Progress	-	809.38	527.38	115.84	76.72	11.73
Leasehold Improvements	-	-	-	-	205.29	-